Develops and markets portable, disposable, instrument-free molecular diagnostic tests for infectious diseases
Develops and markets portable, disposable, instrument-free molecular diagnostic tests for infectious diseases. Its pocket-sized multiplex NAAT platform provides PCR-grade results in about 45 minutes for point-of-care and home use, including COVID-19 and sexually transmitted infection testing. The company also develops lateral-flow tests and provides assay development, prototyping, manufacturing scale-up, and regulatory support.